InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,485.80
(
0.14%
)
US TECH 100
19,287.60
(
0.38%
)
Dow Jones
39,224.11
(
0.25%
)
Brent Oil
85.19
(
0.85%
)
Bitcoin
61,948.02
(
1.85%
)
Post# of 144814
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Peacefulwendy

Send PM Follow Ignore
Followers 55
Posts 2608
Boards Moderated 0
Alias Born 02/04/2014

Peacefulwendy

Re: Mens et Manus post# 37831

Wednesday, 07/01/2015 10:05:34 AM

Wednesday, July 01, 2015 10:05:34 AM

Post# of 144814
TD2 focuses on getting drugs to patients more quickly. This interview with Dr Von Hoff provides insight into his trial designs. After reading this, I understand why they are ensuring they have all the right parameters in preclinicals. It's a good article.

http://www.medelis.com/clinical-cancer-research-abstracts/complete-phase-ib-trial-design/
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent PMCB News
More PMCB News
InvestorsHub NewsWire

FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM

VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM

North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM

Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM

HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM

Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM

Start posting your company's news
Only $200 per official company press release!